Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Zhejiang Conba Pharmaceutical (600572)
- 4.48
- +0.01+0.22%
Market Closed Apr 30 15:00 CST
11.37BMarket Cap23.46P/E (TTM)
4.51High4.43Low502.45KlotVolume4.45Open4.47Prev Close224.62MTurnover1.99%Turnover Ratio23.96P/E (Static)2.54BShares5.1752wk High1.57P/B11.34BFloat Cap4.0452wk Low4.92Limit Up2.53BShs Float11.99Historical High4.02Limit Down1.79%Range %-0.97Historical Low0.15Dividend TTM4.47Avg Price287.16KlotAsk3.35%Div Yield TTM100Lot Size203.63KlotBid
Zhejiang Conba Pharmaceutical (600572) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.10%1.91B | -0.64%6.47B | 1.27%4.98B | -2.61%3.36B | -7.64%1.68B | -3.23%6.52B | -5.23%4.91B | -8.40%3.45B | -14.38%1.82B | 12.20%6.73B |
| Operating revenue | 13.10%1.91B | -0.64%6.47B | 1.27%4.98B | -2.61%3.36B | -7.64%1.68B | -3.23%6.52B | -5.23%4.91B | -8.40%3.45B | -14.38%1.82B | 12.20%6.73B |
| Other operating revenue | ---- | 2.71%91.43M | ---- | 2.46%43.58M | ---- | 10.46%89.02M | ---- | 3.33%42.53M | ---- | 46.66%80.59M |
| Total operating cost | 9.76%1.65B | 0.63%5.93B | 1.50%4.5B | -0.79%3.03B | -4.46%1.51B | -1.65%5.89B | -1.27%4.43B | -4.56%3.05B | -10.73%1.58B | 13.49%5.99B |
| Operating cost | 8.25%824.28M | -0.99%3.02B | 1.17%2.3B | -0.19%1.55B | -2.91%761.43M | 9.20%3.05B | 12.74%2.27B | 10.49%1.56B | 6.98%784.25M | 14.46%2.8B |
| Operating tax surcharges | 13.51%25.7M | 10.23%87.66M | 10.84%66.66M | 11.66%44.69M | -7.65%22.64M | -6.42%79.52M | -2.16%60.15M | -11.09%40.02M | 5.18%24.52M | 14.05%84.98M |
| Operating expense | 13.13%627.13M | 5.60%2.02B | 3.51%1.56B | -2.78%1.06B | -6.16%554.33M | -16.23%1.92B | -18.80%1.51B | -21.83%1.09B | -28.43%590.73M | 10.91%2.29B |
| Administration expense | 6.54%124.67M | -4.05%541.66M | -0.39%392.07M | 3.42%255.82M | -6.76%117.01M | 3.44%564.54M | -0.74%393.61M | -6.74%247.35M | -8.84%125.49M | 4.98%545.78M |
| Financial expense | 136.28%887.15K | 64.92%-6.7M | 53.16%-5.72M | 65.61%-5.11M | 72.82%-2.45M | -2.34%-19.11M | -54.58%-12.21M | -76.27%-14.86M | -717.42%-9M | -30.77%-18.67M |
| -Interest expense (Financial expense) | -35.63%1.5M | -62.50%7.79M | -68.98%6.03M | -71.96%4.08M | -71.54%2.33M | -42.90%20.79M | -38.31%19.42M | -33.39%14.54M | -40.07%8.19M | -26.42%36.4M |
| -Interest Income (Financial expense) | -9.33%-4.64M | 51.11%-17.47M | 61.64%-12.37M | 69.84%-8.19M | 73.38%-4.24M | 32.59%-35.74M | 12.63%-32.26M | -3.85%-27.16M | -19.66%-15.94M | 4.60%-53.01M |
| Research and development | -5.44%49.23M | -12.60%262.22M | -11.76%183.73M | -10.25%119.81M | -12.32%52.07M | 0.65%300.02M | 26.71%208.22M | 43.36%133.5M | 35.68%59.38M | 52.31%298.09M |
| Credit Impairment Loss | 36.75%-2.72M | -572.37%-10.95M | 34.11%-4.06M | 64.68%-2.73M | 32.87%-4.29M | -52.74%-1.63M | 11.58%-6.16M | -36.86%-7.73M | -138.40%-6.4M | -352.58%-1.07M |
| Asset Impairment Loss | -122.85%-9.04M | -88.09%-93.74M | -5.10%-8.03M | 20.64%-9.76M | 67.37%-4.06M | 13.54%-49.84M | 68.82%-7.64M | 19.69%-12.29M | -291.97%-12.44M | 16.54%-57.65M |
| Adjustment items of total operating cost | ---0.01 | ---- | -200.00%-0.01 | --0.01 | ---- | ---- | --0.01 | ---- | ---- | ---- |
| Other net revenue | -109.42%-4.6M | -26.54%129.96M | 32.24%228.26M | 15.16%104.72M | 128.20%48.83M | 270.32%176.92M | 58.78%172.6M | 1.00%90.94M | -55.78%21.4M | 140.44%47.78M |
| Fair value change income | -205.11%-19.85M | 111.52%64.02M | 384.91%114.79M | 1,694.00%34.96M | 614.49%18.88M | 122.43%30.27M | 128.62%23.67M | 93.92%-2.19M | 181.26%2.64M | 31.93%-134.92M |
| Invest income | -35.43%11.93M | 17.86%78.01M | 0.87%56.99M | 2.16%40.88M | 7.97%18.48M | -19.54%66.19M | -36.44%56.5M | -41.57%40.02M | 16.57%17.11M | 143.50%82.26M |
| -Including: Investment income associates | -35.43%11.93M | 18.49%78.37M | 1.08%56.77M | 2.18%40.61M | 10.88%18.48M | 63.82%66.13M | 24.53%56.16M | 13.80%39.74M | 77.82%16.66M | 23.34%40.37M |
| Asset deal income | -93.28%1.53K | -75.75%4.98M | -73.78%5.35M | -70.24%6.34M | -99.51%22.77K | -42.40%20.55M | -52.45%20.42M | 94.93%21.29M | 94,976.59%4.68M | -2.27%35.68M |
| Other revenue | -23.87%15.07M | -21.32%87.63M | -26.34%63.2M | -32.44%35.03M | 25.33%19.8M | -9.79%111.38M | -5.76%85.81M | -23.38%51.85M | -63.10%15.8M | 56.14%123.47M |
| Adjusted Items effecting operating profit | --0.01 | ---- | -200.00%-0.01 | --0.01 | ---- | ---- | --0.01 | ---- | ---- | ---- |
| Operating profit | 8.93%249.01M | -15.73%673.22M | 7.90%707.04M | -10.76%432.36M | -15.42%228.61M | 1.35%798.89M | -18.68%655.29M | -25.87%484.5M | -34.76%270.27M | 30.84%788.27M |
| Add:Non operating Income | 715.10%244.52K | -3.89%2M | -57.30%405.23K | -67.76%168.44K | -90.73%30K | 86.71%2.08M | 1.41%949.1K | -30.27%522.47K | 82.05%323.54K | -39.57%1.11M |
| Less:Non operating expense | -95.10%179.29K | 42.92%30.04M | 25.30%10.7M | 74.97%4.02M | 204.97%3.66M | -3.07%21.02M | -31.94%8.54M | -80.73%2.3M | -88.88%1.2M | 51.72%21.69M |
| Total profit | 10.71%249.08M | -17.28%645.17M | 7.57%696.74M | -11.23%428.51M | -16.49%224.98M | 1.60%779.94M | -18.45%647.7M | -24.86%482.72M | -33.26%269.39M | 30.11%767.69M |
| Less:Income tax cost | 44.09%46.05M | 26.34%153.62M | -0.94%100.56M | -10.93%66.95M | -18.95%31.96M | 30.78%121.59M | 7.63%101.52M | 12.57%75.17M | -49.96%39.43M | -28.43%92.97M |
| Add:Adjusted items effecting net profit | --0.01 | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
| Net profit | 5.19%203.03M | -25.34%491.55M | 9.15%596.18M | -11.29%361.55M | -16.07%193.02M | -2.43%658.35M | -21.96%546.18M | -29.20%407.56M | -29.21%229.96M | 46.64%674.72M |
| Net profit from continuing operation | 5.19%203.03M | -25.34%491.55M | 9.15%596.18M | -11.29%361.55M | -16.07%193.02M | -2.43%658.35M | -21.96%546.18M | -29.20%407.56M | -29.21%229.96M | 46.64%674.72M |
| Less:Minority Profit | 26.32%4.58M | -52.17%17.19M | -56.18%12.15M | -68.66%7.95M | -73.92%3.62M | -56.78%35.94M | -63.83%27.73M | -57.39%25.36M | -65.81%13.9M | -18.48%83.15M |
| Net profit of parent company owners | 4.78%198.45M | -23.79%474.36M | 12.65%584.03M | -7.48%353.61M | -12.34%189.4M | 5.21%622.42M | -16.81%518.46M | -25.95%382.2M | -23.98%216.06M | 65.19%591.57M |
| Earning per share | ||||||||||
| Basic earning per share | 4.00%0.078 | -24.00%0.19 | 13.17%0.232 | -8.67%0.137 | -10.71%0.075 | 8.70%0.25 | -15.64%0.205 | -25.37%0.15 | -24.32%0.084 | 64.29%0.23 |
| Diluted earning per share | 21.88%0.078 | -24.00%0.19 | 13.24%0.231 | -7.43%0.137 | -23.81%0.064 | 8.70%0.25 | -15.35%0.204 | -25.63%0.148 | -24.32%0.084 | 64.29%0.23 |
| Other composite income | 1,246.86%154.78K | 55,913.15%59.42M | 20.59%97.95K | 35.92K | 104.73%11.49K | -2.06%-106.46K | 81.23K | -242.95K | 40.16%-104.31K | |
| Other composite income of parent company owners | 1,246.86%154.78K | 55,913.15%59.42M | 20.59%97.95K | --35.92K | 104.73%11.49K | -2.06%-106.46K | --81.23K | ---- | ---242.95K | 38.35%-104.31K |
| Total composite income | 5.26%203.18M | -16.30%550.97M | 9.16%596.28M | -11.28%361.59M | -15.97%193.03M | -2.43%658.25M | -21.95%546.27M | -29.20%407.56M | -29.29%229.72M | 46.67%674.62M |
| Total composite income of parent company owners | 4.86%198.6M | -14.23%533.78M | 12.65%584.13M | -7.47%353.64M | -12.24%189.41M | 5.21%622.31M | -16.80%518.54M | -25.95%382.2M | -24.06%215.82M | 65.24%591.47M |
| Total composite income of minority owners | 26.32%4.58M | -52.17%17.19M | -56.18%12.15M | -68.66%7.95M | -73.92%3.62M | -56.78%35.94M | -63.83%27.73M | -57.39%25.36M | -65.81%13.9M | -18.47%83.15M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Rongcheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm